title: [Switching to eylea in macular edema due to retinal vascular diseases].
authors.affiliation: Unidad de Mácula, Servicio de Oftalmología, Hospital Universitari i Politècnic La Fe, Valencia, España. Electronic address: i.pascualcamps@gmail.com.
authors.forename: I
authors.initials: I
authors.lastname: Pascual-Camps
authors.affiliation: Unidad de Mácula, Servicio de Oftalmología, Hospital Universitari i Politècnic La Fe, Valencia, España.
authors.forename: P
authors.initials: P
authors.lastname: Hernández-Martínez
authors.affiliation: Servicio de Farmacia, Hospital Universitari i Politècnic La Fe, Valencia, España.
authors.forename: J
authors.initials: J
authors.lastname: Ruiz
authors.affiliation: Unidad de Mácula, Servicio de Oftalmología, Hospital Universitari i Politècnic La Fe, Valencia, España.
authors.forename: R
authors.initials: R
authors.lastname: Dolz-Marco
authors.affiliation: Servicio de Farmacia, Hospital Universitari i Politècnic La Fe, Valencia, España.
authors.forename: M J
authors.initials: MJ
authors.lastname: Cuellar
authors.affiliation: Unidad de Mácula, Servicio de Oftalmología, Hospital Universitari i Politècnic La Fe, Valencia, España.
authors.forename: R
authors.initials: R
authors.lastname: Gallego-Pinazo
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004351:Drug Resistance; D057915:Drug Substitution; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D008028:Light Coagulation; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011446:Prospective Studies; D000069579:Ranibizumab / Q000627:therapeutic use; D040262:Receptors, Vascular Endothelial Growth Factor / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D015861:Retinal Neovascularization / Q000150:complications / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D011993:Recombinant Fusion Proteins; C533178:aflibercept; D040262:Receptors, Vascular Endothelial Growth Factor; D000069579:Ranibizumab